Office of Biomedical Advanced Research and Development Authority Broad Agency Announcement (BAA)

This Broad Agency Announcement from the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response seeks proposals to support advanced research and development of medical countermeasures across 14 areas of interest, including vaccines, therapeutics, diagnostics, and enabling technologies to counter chemical, biological, radiological, nuclear and emerging infectious disease threats. Proposals must address opportunities at technology readiness level 5 or higher and involve activities to support development through late-stage trials toward FDA approval and licensure. Evaluation will be based on the ability to advance products toward FDA approval and experience developing countermeasures. The final white paper and full proposal submission deadline is October 31, 2020.

There is no set-aside designated for this procurement. Awards will be made through contracts or other transaction agreements to support advanced development activities. Preferences include proposals demonstrating cost-sharing partnerships with industry and experience manufacturing proposed products at scale. Successful proposals will improve medical countermeasure preparedness and response capabilities against threats domestically and internationally.